Clinical Trial Update: Single Dose Thymoglobulin for Induction in Adult Renal Allograft Recipients [NA]

View source ↗

Summary

A clinical trial update notes termination of a study evaluating a single-dose Thymoglobulin induction regimen in adult kidney transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Thymoglobulin (rabbit anti-thymocyte globulin)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Kidney Transplantation | NA | Status: TERMINATED